कनाडा - अंग्रेज़ी - Health Canada

alk-abello inc - non pollen - liquid - 100000unit - non pollen 100000unit - allergenic extracts

कनाडा - अंग्रेज़ी - Health Canada

alk-abello inc - pollen - liquid - 100000unit - pollen 100000unit - allergenic extracts

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - spironolactone, quantity: 100 mg - tablet, uncoated - excipient ingredients: sunset yellow fcf aluminium lake; maize starch; povidone; magnesium stearate; peppermint oil; sodium starch glycollate; purified talc; erythrosine aluminium lake; polysorbate 80; quinoline yellow aluminium lake; lactose monohydrate; microcrystalline cellulose - essential hypertension. spironolactone, when used alone, is effective in lowering both systolic and diastolic blood pressure. spironolactone improves the hypotensive action of thiazide diuretics, while at the same time reducing or preventing potassium loss due to the thiazide. spironolactone enhances the effectiveness of other antihypertensive agents such as beta-blockers, vasodilators, etc. as adjunctive therapy in malignant hypertension. in diuretic induced hypokalaemia when other measures are considered inappropriate or inadequate. prophylaxis of hypokalaemia in patients taking digitalis when other measures are considered inadequate or inappropriate. congestive cardiac failure. when used alone, spironolactone is effective in the management of oedema and sodium retention associated with congestive cardiac failure. spironolactone may be used in combination with a thiazide or other conventional diuretics for achieving diuresis in patients whose oedema is resistant to a thiazide or other conventional diuretics

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - esmolol hydrochloride, quantity: 100 mg - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium acetate trihydrate; glacial acetic acid - supraventricular tachycardia - for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other emergent circumstances where short term control of ventricular rate with a short-acting agent is desirable. esmolol is also indicated in non-compensatory sinus tachycardia where, in the physician's judgement, the rapid heart rate requires specific intervention. esmolol is not intended for use in chronic settings where transfer to another agent is anticipated, or for treatment periods greater than 24 hours duration.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - aluminium sulfate hydrate, quantity: 200 mg/ml - gel - excipient ingredients: purified water; colloidal anhydrous silica; nonoxinol 10; sodium laureth sulfate; fragrance (perfume); sodium lauryl sulfate; sodium cetostearyl sulfate; laureth-10 - helps to minimise the pain, inflammation, and itching associated with stings and bites of most insects and plants, including ants, bees, wasps, mosquitos, sandflies, sea lice, vines and nettles.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - esmolol hydrochloride, quantity: 100 mg - injection, solution - excipient ingredients: glacial acetic acid; sodium acetate trihydrate; sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - esmolol hydrochloride medsurge is indicated for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other emergent circumstances where short term control of ventricular rate with a short-acting agent is desirable. esmolol hydrochloride medsurge is also indicated in non-compensatory sinus tachycardia where, in the physician?s judgement, the rapid heart rate requires specific intervention. esmolol hydrochloride medsurge is not intended for use in chronic settings where transfer to another agent is anticipated or for treatment periods greater than 24 hours duration.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

ebos group ltd - allergen extracts 100 pnu/ml (horse epithelium, pyridine extract, alum precip. liq. ext.); allergen extracts 1000 pnu/ml (horse epithelium, pyridine extract, alum precip. liq. ext.); allergen extracts 10000 pnu/ml (horse epithelium, pyridine extract, alum precip. liq. ext.) - suspension for injection - active: allergen extracts 100 pnu/ml (horse epithelium, pyridine extract, alum precip. liq. ext.) excipient: aluminium hydroxide phenol sodium chloride water for injection active: allergen extracts 1000 pnu/ml (horse epithelium, pyridine extract, alum precip. liq. ext.) excipient: aluminium hydroxide phenol sodium chloride water for injection active: allergen extracts 10000 pnu/ml (horse epithelium, pyridine extract, alum precip. liq. ext.) excipient: aluminium hydroxide phenol sodium chloride water for injection

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

stallergenes greer new zealand ltd - grass pollen extract 100 ir; allergen extracts 300 ir (grass pollen) - sublingual tablet - active: grass pollen extract 100 ir excipient: colloidal silicon dioxide croscarmellose sodium lactose magnesium stearate microcrystalline cellulose active: allergen extracts 300 ir (grass pollen) excipient: colloidal silicon dioxide croscarmellose sodium lactose magnesium stearate microcrystalline cellulose - treatment of grass pollen allergic rhinitis with or without conjunctivitis in adults, adolescents and children (above the age of 5) with clinically relevant symptoms, confirmed by a positive cutaneous test and/or a positive titre of the specific ige to the grass pollen.

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

nelco laboratories, inc. - bos taurus skin (unii: 7j12cd6o9l) (bos taurus skin - unii:7j12cd6o9l) - bos taurus skin 20000 [pnu] in 1 ml - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

nelco laboratories, inc. - bos taurus skin (unii: 7j12cd6o9l) (bos taurus skin - unii:7j12cd6o9l) - bos taurus skin 10000 [pnu] in 1 ml - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t